Halberd

Halberd OCF Margin

The Operating Cash Flow Margin of Halberd (HALB) as of Oct 10, 2026 is -5,168.77 %. In the previous year, Operating Cash Flow Margin was -8,834.50 % — a change of -41.49% (higher).

OCF Margin

-5,168.77 %

YoY

-41.49%

Last updated:

Operating Cash Flow Margin of Halberd is 2024 -5,168.77 % . Operating Cash Flow Margin of Halberd was 2023 -8,834.50 % . It decreases by -41.49% higher compared to the previous year.

The Halberd OCF Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

OCF Margin
Date
OCF Margin
Jan 1, 2016
-0.18 USD
Jan 1, 2017
-0.43 USD
Jan 1, 2021
-14,705.98 USD
Jan 1, 2022
-11,475.47 USD
Jan 1, 2023
-8,834.50 USD
Jan 1, 2024
-5,168.77 USD
The Halberd OCF Margin history
YEAROCF MarginYoY
-5,168.77 %-41.49%
-8,834.50 %-23.01%
-11,475.47 %-21.97%
-14,705.98 %+3.38 M%
-0.43 %+137.41%
-0.18 %—
Access this data via the Eulerpool API

Halberd Stock analysis

What does Halberd do? The Halberd Corp is an American company founded in 1987 and based in New York. It is a high-tech company focused on the development of medical technologies. Since its inception, the company has developed numerous innovative products and technologies that are used worldwide. A significant portion of Halberd Corp's business model focuses on providing medical products and solutions for various diseases. The main divisions of the company are biotechnology and pharmaceuticals, medical respiratory protection, medical technology, and the development of antibodies and diagnostics. Some of the most well-known products of Halberd Corp are the Medical Respiratory Masks, which were of great importance during the COVID-19 pandemic. These masks were developed and distributed worldwide by the company with innovative technology and the highest quality standards. The company has also developed various medical devices such as infusion pumps, blood pressure monitors, and various diagnostic devices that have been used by hospitals and care facilities. Another important business area of Halberd Corp is biotechnology and pharmaceuticals. In this field, the company specializes in developing new drugs and therapies for various diseases. The company has developed a range of proprietary medications that are used in the treatment of various diseases. Halberd Corp is also known for its development of antibodies and diagnostics and offers corresponding test kits. In recent years, Halberd Corp has formed numerous partnerships with other companies and institutions to bring its innovations to the market and market them. The company is also known for its successful joint ventures with other companies in the healthcare sector. Overall, Halberd Corp is an innovative company focused on medical technologies. With its presence in various areas of the healthcare industry, the company is able to develop new products and solutions that have the potential to improve and save lives. Halberd is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Halberd stock

Operating Cash Flow Margin of Halberd is -5,168.77 % in 2024.

Operating Cash Flow Margin of Halberd changed from -8,834.50 % to -5,168.77 %, representing a -41.49% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow Margin Halberd since 2006 – with annual values, charts, and detailed analysis.

OCF margin measures the percentage of revenue converted into operating cash flow. It indicates cash generation efficiency from core business operations.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Cash Flow Margin's Halberd with sector peers and the industry average to assess whether it is attractive.

To evaluate Operating Cash Flow Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Operating Cash Flow Margin.

Access this data via the Eulerpool API

Margins — Halberd

All Key Metrics — Halberd